Investigating treatment response and immune profile in association with pattern identification in NSCLC patients scheduled for immune checkpoint inhibitor monotherapy (HARMONY study)

Author:

Jang Jung-Hee,Jun Hyeong Joon,Choi Yujin,Kim Jin Chul,Jang Ho,Park Sang-Min,Kwon Ojin,Choi Chang-Min,Kim Seung Joon,Choi Jong Gwon,Son Ji Woong,Lee Seung Hyeun,Jang Tae-Won,Yoon Seong Hoon,Ryu Jeong-Seon,Lim Jun Hyeok,Jang Seung-Hun,Oh In-Jae,Lee Sung Yong,Jeong Mi-Kyung

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Psychiatry and Mental health

Reference32 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.;Bray;CA Cancer J Clin,2018

2. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship.;Molina;Mayo Clin Proc,2008

3. Monitoring immune-checkpoint blockade: response evaluation and biomarker development.;Nishino;Nat Rev Clin Oncol,2017

4. Association of survival and immune-related adverse events with Anti-PD-1/PD-L1 and Anti-CTLA-4 inhibitors, alone or their combination for the treatment of cancer: a systematic review and meta-analysis of 13 clinical trials.;Zhang;Front Oncol,2021

5. A changing of the guard: immune checkpoint inhibitors with and without chemotherapy as first line treatment for metastatic non-small cell lung cancer.;Pacheco;Front Oncol,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3